National Allergy Strategy - Why MedicAlert is part of the conversation 20 April 2026 MedicAlert Today marks an important moment for allergy care in the UK. Healthcare leaders, charities and policymakers are coming together to discuss one clear priority: the need for a coordinated National Allergy Strategy. MedicAlert is proud to be part of that conversation, supporting a future where people living with allergies feel safer, better understood and fully protected. The urgency behind the strategy Allergy is not a niche issue. It affects millions across the UK, with growing numbers of people living with conditions that can be life altering and, in some cases, life threatening. Yet despite this, care remains inconsistent. Families continue to face delayed diagnoses, limited access to specialists and support. Behind every statistic is a real person navigating uncertainty. A child at school. A young adult living independently. A parent managing daily risk. This is why today’s event matters. A step towards national change The UK National Allergy Strategy aims to create the first coordinated, UK wide approach to allergy prevention, diagnosis and management. It brings together leading organisations including Allergy UK, Anaphylaxis UK and the Natasha Allergy Research Foundation to address long standing gaps in care. The focus is clear: Improve access to timely diagnosis and specialist care Strengthen education and training for healthcare professionals Reduce inequalities in treatment across the UK Improve emergency response and patient safety This is more than policy. It is about saving lives and improving everyday confidence. Where MedicAlert fits in At MedicAlert, we see first hand the reality of living with allergies. We support individuals who need their vital medical information to be instantly accessible in an emergency. Because when seconds matter, clarity saves lives. This aligns directly with the ambition of the National Allergy Strategy. A medical ID is not just a product. It is reassurance. It is confidence. It is protection when someone can not speak for themselves. MedicAlert CEO, Rob Burley, will be attending the event to share his views and help align the future of MedicAlert with the strategy. Looking ahead Today’s discussions are an important step forward. But as many experts have highlighted, strategy alone is not enough. Delivery is what will truly make the difference. MedicAlert will continue to support this movement, working alongside partners and advocates to ensure people living with allergies are protected, understood and empowered Article Categories MedicAlert News Health and Wellbeing Medical Conditions Allergies